Official ESCRS | European Society of Cataract & Refractive Surgeons


Micropulse transscleral cyclophotocoagulation for the management of glaucoma after silicone oil removal in vitrectomized eyes

Search Title by author or title

Session Details

Session Title: Glaucoma


First Author: : A.Samir SAUDI ARABIA

Co Author(s): :    A. AlQarni   M. Almalis                    

Abstract Details


The purpose of this study was to report the preliminary results of a novel micropulse transscleral diode laser cyclophotocoagulation  as primary therapy for persistent glaucoma after silicone oil removal in vitrectomized eyes


a retrospective non comparative study was conducted in Magrabi Eye centers Jeddah Saudi Arabia


a retrospective interventional case series of 32 eyes of 28 consecutive patients with glaucoma resistant to medical treatment for 6 months after silocone oil removal were treated by micropulse transscleral cyclophotocoagulation.  Outcomes measured were postoperative IOP, visual outcome, hypotony and recurrence rates.


The mean age of patients was 58.2 +/- 7.0 years. The mean follow-up period was 12.3 +/- 3.5 months. The mean intraocular pressure (IOP) before micropulse cyclophotocoagulation was 42.3 +/- 10.6 mmHg. Mean IOP decreased to 26.1 +/- 13.4 mmHg at 1 day, 23.0 +/- 7.0 mmHg at 1 week, 20.4 +/- 4.7 mmHg at 1 month,  20.8 +/- 6.5 mmHg at 6 months and  18.6 +/- 5.7 mmHg at 12 months  (P < 0.001 at all time points). No patient had hypotony or loss of best-corrected visual acuity. Twenty eight eyes had one session, 4 eyes had two sessions.


MicroPulse transscleral cyclophotocoagulation is a safe and effective method of lowering IOP in cases of refractory glaucoma after silicone oil removal in vitrectomized eyes

Financial Disclosure:


Back to previous